The lung cancer vaccine race has brought together an unusual mix of players. Merck KGaA was in a good position, but its vaccine disappointed in Phase III, while GlaxoSmithKline could report data on its candidate this year. Then there is the Cuba-Argentina joint venture.
It's been a busy week or two for GlaxoSmithKline ($GSK)--the company has extended its agreement with Agenus ($AGEN), submitted two vaccines for approval and created a joint venture.
Inovio has created a SynCon DNA vaccine against HPV6 and HPV11, which, in a preclinical trial published in Human Vaccines & Immunotherapeutics, triggered a strong immune response in mice.
Targeting a variety of tumor types, the Roswell Park Cancer Institute has begun recruiting patients for an early-stage clinical trial to test an experimental cancer vaccine. The vaccine, or...
Oncothyreon ($ONTY) execs are expecting interim results from a late-stage study of lung cancer vaccine Stimuvax sometime this quarter. Results from the 1,514-person trial, which is being conducted by...
Cuba has commenced sales of the world's first therapeutic lung cancer vaccine this week after 25 years of research at the Center of Molecular Immunology in Havana, according to Xinhua. "The drug
Scientists at St. George's, University of London, have found a way to assist the body's immune system against cancer using an old tuberculosis remedy. A vaccine created with the germ Baculillus
Merck KGaA got the green light from the FDA to restart its late-stage lung cancer program for its therapeutic vaccine Stimuvax, which had been halted after a patient in a multiple myeloma trial